3Richardson DR. Novel Chelators for central nervous system disorders that involve alterations in the metabolism of iron and other metal ions[J]. Annals of the New York Academy of Sciences, 2006, 1012 ( 1 ) : 326-41.
4Herran, M. T. Garcia-Unzueta, M. D. Fem~mdez-GonzOlez, et al. Higher levels of serum copper in schizophrenic patients treated with depot neuroleptics [ J ]. Psychiatry research, 2000, 94 ( 1 ) : 51-58.
5Barbara Nowak and Chmielnicka, Relationship of lead and Cadmium to Essential Elements in Hair, Teeth, and Nails of Environmentally Exposed people,2000 (46) :265-274.
6Cadet JL. Free radical mechanisms in the central nervous system: an overview[ J]. Int J Neumsci, 1988,40(1/2) :13.
7Yasui M, Yase Y, Ando K, et al. Magnesium concentration in brains from muhiplc sclerosis patients [ J ]. Acta Neural Stand, 1990, 81 (3) :197.
8BrissosS,Balanza-Martinez V,Dias VV,et al. Is personal and social functioningassociated with subjective quality of life in schizophrenia patients living in thecommunity[J]. Eur Arch Psychiatry Clin Neurosci,2011,261 (7) :509-517.
9Monika S,An P,Daniela J ,et al. The quality of life of patients suffering fromschi-zophrenia-acomparison with healthy con- trois [J]. Biomed Pap Med Fac UnivPalacky Olomouc Czech Repub,2011,155(2) : 173-180.
